SK118794A3 - 4(4'-piperidinyl or 3'- pyrrolidinyl) substitutes imidazoles as h3-receptor - Google Patents

4(4'-piperidinyl or 3'- pyrrolidinyl) substitutes imidazoles as h3-receptor Download PDF

Info

Publication number
SK118794A3
SK118794A3 SK1187-94A SK118794A SK118794A3 SK 118794 A3 SK118794 A3 SK 118794A3 SK 118794 A SK118794 A SK 118794A SK 118794 A3 SK118794 A3 SK 118794A3
Authority
SK
Slovakia
Prior art keywords
compound
alertness
group
subject
compounds
Prior art date
Application number
SK1187-94A
Other languages
English (en)
Slovak (sk)
Inventor
Graham J Durant
Amin M Khan
Original Assignee
Univ Toledo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Toledo filed Critical Univ Toledo
Publication of SK118794A3 publication Critical patent/SK118794A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
SK1187-94A 1992-04-01 1993-03-31 4(4'-piperidinyl or 3'- pyrrolidinyl) substitutes imidazoles as h3-receptor SK118794A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86265792A 1992-04-01 1992-04-01
PCT/US1993/003104 WO1993020061A1 (fr) 1992-04-01 1993-03-31 Imidazoles substitues de 4-[4'-piperidinyl ou de 3'-pirrolidinyl] en tant qu'antagonistes du recepteur h3 et utilisations therapeutiques

Publications (1)

Publication Number Publication Date
SK118794A3 true SK118794A3 (en) 1995-06-07

Family

ID=25338976

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1187-94A SK118794A3 (en) 1992-04-01 1993-03-31 4(4'-piperidinyl or 3'- pyrrolidinyl) substitutes imidazoles as h3-receptor

Country Status (13)

Country Link
US (1) US5633382A (fr)
EP (1) EP0633882A1 (fr)
JP (1) JPH07509219A (fr)
KR (1) KR950700902A (fr)
AU (1) AU3944593A (fr)
BR (1) BR9306190A (fr)
CA (1) CA2133461A1 (fr)
FI (1) FI944605A7 (fr)
HU (1) HUT71353A (fr)
NO (1) NO943687L (fr)
RU (1) RU94044337A (fr)
SK (1) SK118794A3 (fr)
WO (1) WO1993020061A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5463074A (en) * 1991-12-18 1995-10-31 Schering Corporation Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
US6407132B1 (en) 1997-07-25 2002-06-18 James Black Foundation Limited Substituted imidazole derivatives and their use as histamine H3 receptor ligands
US6436966B1 (en) * 1997-10-27 2002-08-20 Takeda Chemical Ind., Ltd. Adenosine A3 receptor antagonists
WO2000042023A1 (fr) 1999-01-18 2000-07-20 Novo Nordisk A/S Imidazoles substitues, leur preparation et utilisation
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
AU3957600A (en) * 1999-04-26 2000-11-10 Boehringer Ingelheim International Gmbh Piperidyl-imidazole derivatives, their preparations and therapeutic uses
DE19940130A1 (de) 1999-08-24 2001-03-01 Probiodrug Ges Fuer Arzneim Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
US6437147B1 (en) 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
US6610721B2 (en) 2000-03-17 2003-08-26 Novo Nordisk A/S Imidazo heterocyclic compounds
ATE354568T1 (de) 2000-08-08 2007-03-15 Ortho Mcneil Pharm Inc Nicht-imidazol aryloxypiperidine als h3 rezeptor liganden
ES2260276T3 (es) 2000-08-08 2006-11-01 Ortho-Mcneil Pharmaceutical, Inc. Ariloxialquilaminas no imidazolicas como ligandos del receptor h3.
ATE323076T1 (de) 2000-08-08 2006-04-15 Ortho Mcneil Pharm Inc Bicyclische verbindungen als h3 rezeptor liganden
FR2818978B1 (fr) * 2000-12-28 2003-02-28 Sod Conseils Rech Applic Modulateurs de canaux sodiques derives de 2-piperidylimidazoles
US20030130199A1 (en) 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
CN1625554A (zh) * 2002-02-01 2005-06-08 诺沃挪第克公司 氨基烷基－取代的氮杂环丁烷、吡咯烷、哌啶与氮杂环庚烷的酰胺
US7332508B2 (en) * 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
WO2004098591A2 (fr) * 2003-05-05 2004-11-18 Probiodrug Ag Inhibiteurs de glutaminyl-cyclase
CN1784220B (zh) * 2003-05-05 2011-08-03 前体生物药物股份公司 谷氨酰胺酰基和谷氨酸环化酶效应物的应用
EP1961416B1 (fr) 2003-05-05 2013-01-23 Probiodrug AG Utilisation d'inbiteurs de glutaminyl cyclase pour le traitement de la polyarthrite rhumatoïde, du psoriasis ou de l'athersclérose
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
BRPI0415409A (pt) 2003-10-15 2006-12-05 Probiodrug Ag uso de efetuadores de ciclases de glutaminila e glutamato
CA2554809C (fr) 2004-02-05 2014-04-29 Probiodrug Ag Nouveaux inhibiteurs de la glutaminyl-cyclase comportant de la n thiouree alkyle et de l'imidazolyl substitue par thioamide
EP1816912A4 (fr) * 2004-11-23 2008-09-10 Merck & Co Inc Traitement des accidents vasculaires cerebraux utilisant des agonistes inverses de l'histamine h3 ou des antagonistes de l'histamine h3
WO2013151982A1 (fr) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés
JP2017100949A (ja) * 2014-04-01 2017-06-08 大日本住友製薬株式会社 ５員環ヘテロアリール誘導体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2579596B1 (fr) * 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
FR2586562B1 (fr) * 1985-09-02 1989-03-10 Inst Nat Sante Rech Med Composition pharmaceutique contenant de l'a-methylhistamine
FR2630328B1 (fr) * 1988-04-22 1990-08-24 Inst Nat Sante Rech Med Derive de l'histamine, sa preparation et son application en therapeutique
FR2661909B1 (fr) * 1990-05-09 1997-08-14 Inst Nat Sante Rech Med Nouveaux composes agonistes du recepteur h3 de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation.
FR2671083B1 (fr) * 1990-12-31 1994-12-23 Inst Nat Sante Rech Med Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.
US5070101A (en) * 1991-02-14 1991-12-03 Mount Sinai School Of Medicine Of The City University Of New York Method and pharmaceutical composition for the treatment of schizophrenia

Also Published As

Publication number Publication date
HUT71353A (en) 1995-11-28
FI944605A7 (fi) 1994-11-30
NO943687L (no) 1994-11-21
EP0633882A1 (fr) 1995-01-18
AU3944593A (en) 1993-11-08
BR9306190A (pt) 1998-06-23
WO1993020061A1 (fr) 1993-10-14
NO943687D0 (no) 1994-10-03
FI944605A0 (fi) 1994-10-03
JPH07509219A (ja) 1995-10-12
US5633382A (en) 1997-05-27
RU94044337A (ru) 1996-08-10
KR950700902A (ko) 1995-02-20
HU9402827D0 (en) 1994-12-28
CA2133461A1 (fr) 1993-10-14

Similar Documents

Publication Publication Date Title
SK118794A3 (en) 4(4'-piperidinyl or 3'- pyrrolidinyl) substitutes imidazoles as h3-receptor
RU2351596C2 (ru) Производные n-[гетероарил(пиперидин-2-ил)метил]бензамида и их применение в терапии
RU2089547C1 (ru) Производные n-алкиленпиперидина, способ их получения, фармацевтическая композиция на их основе, оптически чистые производные n-алкиленпиперидина
JP3798337B2 (ja) 新規α−アミノ酸化合物、その調製方法及びそれを含有する医薬組成物
EP1499589B1 (fr) Derives de n-¬phenyl(piperidin-2-yl)methyl|benzamide, leur preparation et leur application en therapeutique
RU2351588C2 (ru) Производные n-фенил(пиперидин-2-ил)метил-бензамида и их применение в терапии
RU2386614C2 (ru) Производные n-[фенил(пирролидин-2-ил)метил]бензамида и n-[(азепан-2-ил)фенилметил]бензамида, способ их получения и их применение в терапии
US5486526A (en) Histamine H3 -receptor antagonists and therapeutic uses thereof
US20120094989A1 (en) 5-ht receptor modulating compounds
WO2017117556A1 (fr) Modulateurs allostériques positifs du récepteur au glp-1
WO2022212707A1 (fr) Inhibiteurs de protéase 3cl du sars
KR20120098720A (ko) 알파 아드레날린 수용체 변형제
US11292783B2 (en) Substituted 1,2,3,4-tetrahydroisoquinolines as kappa opioid antagonists
US6303638B1 (en) Substituted pyridines as modulators of the mammalian neuronal nicotinic acetylcholine receptor
JP2004521096A (ja) アデノシン受容体リガンドとしてのアミノトリアゾロピリジン誘導体
EP4074697A2 (fr) Nouveaux dérivés d'adamantane en tant qu'inhibiteurs de kinase d'adhérence focale
JPS6230762A (ja) 新規５−オキソ−１−イミダゾリジンアセトアミド誘導体
US5639775A (en) 4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H3 -receptor antagonists and therapeutic uses thereof
WO2013086266A2 (fr) Modulateurs allostériques du récepteur 2c de la 5-hydroxytryptamine (5‑ht2cr)
CN121335897A (zh) 作为cd38抑制剂用于治疗cns病症的1,3-噻唑和1,2,4-噻二唑
EP3935059B1 (fr) Modulateurs de la signalisation des récepteurs ampa
US20080318966A1 (en) Sinomenine Derivatives and Preparation and Uses Thereof
SK462001A3 (en) Compounds, compositions, and methods for stimulating neuronal growth and elongation
US20070021484A1 (en) Substituted N-cinnamyl benzamides
US9409876B2 (en) Bradykinin receptor antagonists and pharmaceutical compositions containing them